Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
Connecticut [US], May 21 (ANI): A team of scientists discovered novel immune checkpoints that have applications for cancer, autoimmune disease treatment. The immune system is a complex balancing act; if it overreacts or underreacts to foreign molecules, there can be serious health consequenc